A meningococcal group C conjugate vaccine was introduced into the routine schedule in the UK
In 1999, a meningococcal group C conjugate vaccine was introduced into the routine schedule in the U.K. for…
In 1999, a meningococcal group C conjugate vaccine was introduced into the routine schedule in the U.K. for…
On April 4, 1997, the Immunization Practices Advisory Committee (ACIP) recommended that the vaccine be used more extensively…
On Dec. 21, 1988, the conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed. Prior to…
On Jan. 22, 1988, the Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP) recommended…
On Nov. 23, 1981, the U.S. Food and Drug Administration (FDA) licensed Quadrivalent groups A, C, Y, and…
On Jan. 3, 1978, the U.S. Food and Drug Administration (FDA) licensed the Monovalent group A (Menomune-A by…
On Apr. 2, 1974, the U.S. Food and Drug Administration (FDA) licensed the first monovalent (group C) meningococcal…
In 1955, Edward Robitzek, Irving Selikoff, Walsh McDermott and Carl Muschenheim, The Hoffmann-La Roche Research Laboratories, Squibb Institute…
In 1938, Margaret Pittman showed that the precipitin reaction around meningococcus colonies on immune serum agar plates was…
In 1937, Margaret Pittman, Sara E. Branham, and E. M. Sockrider showed the type specificity of meningococcus by…
In 1930, Sara E. Branham identified a new organism, Neisseria flavescens, as a rare cause of meningitis and…